Table 2. Treatment on admission and at discharge of the study cohort stratified according to gender (n = 7930).
| Men(n = 6244) | Women(n = 1686) | P-value | |
| Admission medical treatment | |||
| Aspirin | 6145 (98.4) | 1656 (98.2) | 0.588 |
| Clopidogrel | 4947 (79.2) | 1094 (64.9) | <0.001 |
| BB | 4705 (75.4) | 1190(70.6) | <0.001 |
| CCB | 390 (6.2) | 186 (11.0) | <0.001 |
| ACE | 4420 (70.8) | 1184 (70.2) | 0.651 |
| AIIRB | 262 (4.2) | 132 (7.8) | <0.001 |
| Statins | 5936 (95.1) | 1578 (93.6) | 0.019 |
| Insulin | 1707 (27.3) | 641 (38.0) | <0.001 |
| OHA | 406 (6.5) | 179 (10.6) | <0.001 |
| In-hospital invasive procedures | |||
| Cardiac angiography | 2120 (34.0) | 456 (27.0) | <0.001 |
| PCI | 971 (15.6) | 177 (10.5) | <0.001 |
| CABG | 193 (3.1) | 40 (2.4) | 0.125 |
| Reperfusion therapy | 1259 (20.2) | 117 (6.9) | <0.001 |
| Discharge medical treatment | |||
| Aspirin | 5834 (93.5) | 1523 (90.4) | <0.001 |
| Clopidogrel | 4439(71.1) | 924 (54.8) | <0.001 |
| BB | 5020 (80.6) | 1248 (74.3) | <0.001 |
| CCB | 415 (6.7) | 203 (12.1) | <0.001 |
| ACE | 4501 (72.3) | 1140 (67.9) | <0.001 |
| AIIRB | 369 (5.9) | 167 (9.9) | <0.001 |
| Statins | 5735 (92.1) | 1482 (88.2) | <0.001 |
| Insulin | 747 (12.0) | 374 (22.3) | <0.001 |
| OHA | 1486 (23.9) | 513 (30.5) | <0.001 |
Figures in parentheses are percentages. Abbreviations: BB, beta-blockers; CCB, calcium channel blockers; ACE, angiotensin-converting enzyme inhibitors; AIIRB, angiotensin II receptor blockers; OHA, oral hypoglycemic agents; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.